Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc expected to post a loss of 1 cent a share - Earnings Preview

* Alimera Sciences Inc  ALIM.OQ   ALIM.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 8
(estimated) for the period ending September 30 2024
    * The Alpharetta Georgia-based  company is expected to
report a
17.4% increase in revenue to $27.438 million from $23.36 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Alimera Sciences Inc is
for a
loss of 1 cent per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 175.1% in the last three months. ​
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $5.50​, below​ its last closing price of $5.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.06       -0.06      -0.06     Met     -63.6
 Mar. 31 2024  -0.06       -0.06      -0.12     Missed  -111.8
 Dec. 31 2023              0.00       -0.07     Missed  ​
 Sep. 30 2023  -0.07       -0.06      -0.06     Met     7
 ​​Jan.        0.00        0.02       -1.32     Missed  -8,900
 1 0001                                                 
 Mar. 31 2023  -0.51       -0.32      -0.71     Missed  -121.9
                                                        ​
 Dec. 31 2022              -0.33      -0.54     Missed  -61.2
 Sep. 30 2022  -0.40       -0.40      -0.75     Missed  -86
 This summary was machine generated August 6 at 18:35 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Alimera Sciences

See all news